Skip to Content

Ono Pharmaceutical Co Ltd ADR OPHLY

Morningstar Rating
$4.75 +0.12 (2.59%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

OPHLY is trading at a 695% premium.
Price
$4.76
Fair Value
$5.30
Uncertainty
High
1-Star Price
$2.63
5-Star Price
$9.76
Economic Moat
Gbnl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OPHLY is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$4.63
Day Range
$4.694.77
52-Week Range
$4.326.72
Bid/Ask
$4.63 / $4.85
Market Cap
$6.69 Bil
Volume/Avg
69,606 / 174,229

Key Statistics

Price/Earnings (Normalized)
8.16
Price/Sales
1.97
Dividend Yield (Trailing)
3.66%
Dividend Yield (Forward)
3.66%
Total Yield
8.82%

Company Profile

Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Mid Value
Total Number of Employees
3,853

Comparables

Valuation

Metric
OPHLY
4502
4581
Price/Earnings (Normalized)
8.1616.3127.83
Price/Book Value
1.280.930.84
Price/Sales
1.971.592.17
Price/Cash Flow
7.087.7914.48
Price/Earnings
OPHLY
4502
4581

Financial Strength

Metric
OPHLY
4502
4581
Quick Ratio
3.290.514.20
Current Ratio
3.991.115.16
Interest Coverage
698.411.3568.75
Quick Ratio
OPHLY
4502
4581

Profitability

Metric
OPHLY
4502
4581
Return on Assets (Normalized)
15.67%5.19%2.57%
Return on Equity (Normalized)
18.10%11.01%3.09%
Return on Invested Capital (Normalized)
17.38%7.28%2.64%
Return on Assets
OPHLY
4502
4581
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
KcwqlsrhPslp$853.9 Bil
Johnson & Johnson
JNJ
DbrmyvgjpHbz$360.7 Bil
Merck & Co Inc
MRK
GqyrpxxnCfhqn$323.6 Bil
AbbVie Inc
ABBV
RrmsxdcfKhylw$300.7 Bil
AstraZeneca PLC ADR
AZN
BhgvyxktLflf$245.6 Bil
Roche Holding AG ADR
RHHBY
ScjdxqxpzNwhg$229.9 Bil
Novartis AG ADR
NVS
XnltzvkSnmw$227.8 Bil
Amgen Inc
AMGN
VrskvchhpCgrp$177.5 Bil
Pfizer Inc
PFE
QzfrvjgFjykq$163.9 Bil
Sanofi SA ADR
SNY
GdfmxlklsQmh$128.4 Bil

Sponsor Center